Testing effectiveness (Phase 2)Study completedNCT00042003
What this trial is testing
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40